F

Filament Health Corp
NEO:FH

Watchlist Manager
Filament Health Corp
NEO:FH
Watchlist
Price: 0.01 CAD -33.33% Market Closed
Market Cap: CA$2.6m

Filament Health Corp
Investor Relations

Filament Health Corp. is a Canada-based natural psychedelic drug discovery and development company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-06-24. The firm is engaged in natural extraction technologies utilizing patented and patent-pending processes to manufacture standardized, pharmaceutical grade psychoactive products. The firm operates through its Health Canada Dealer’s license at its good manufacturing practice (GMP) drug discovery and manufacturing facility. The Company’s subsidiary includes Psilo Scientific Ltd. (Psilo). Psilo is a drug discovery and extraction technologies company.

Show more
Loading
FH
S&P TSX Composite Index (Canada)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Benjamin Lightburn
Co-Founder, CEO & Chairman
No Bio Available
Ms. Lisa Ranken
Chief Operating Officer
No Bio Available
Mr. Ryan Moss
Chief Science Officer
No Bio Available
Mr. Jonathan Conlin
Corporate Secretary & Director
No Bio Available
Mr. Steven Nguyen CPA
Interim Chief Financial Officer
No Bio Available
Ms. Anna Cordon
Vice President of Marketing & Communications
No Bio Available
Mr. Jeff Fellows
Head of Regulatory
No Bio Available
Andry Tjahyana
VP of Business Development
No Bio Available
Sara Burke B.A., M.B.A.
Head of Global Partnerships
No Bio Available

Contacts

Address
BRITISH COLUMBIA
Vancouver
2900 - 550 Burrard Street
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett